JY, L., JE, L., M, L., H, S., SI, P., SA, P., . . . SW, K. (2026). SSEA3 and CD105 positivity are associated with the treatment potency of human neural crest-derived nasal turbinate stem cells for Alzheimer's disease. Translational neurodegeneration, 15(1), . https://doi.org/10.1186/s40035-026-00539-3
Chicago Style (17th ed.) CitationJY, Lim, et al. "SSEA3 and CD105 Positivity Are Associated with the Treatment Potency of Human Neural Crest-derived Nasal Turbinate Stem Cells for Alzheimer's Disease." Translational Neurodegeneration 15, no. 1 (2026). https://doi.org/10.1186/s40035-026-00539-3.
MLA (9th ed.) CitationJY, Lim, et al. "SSEA3 and CD105 Positivity Are Associated with the Treatment Potency of Human Neural Crest-derived Nasal Turbinate Stem Cells for Alzheimer's Disease." Translational Neurodegeneration, vol. 15, no. 1, 2026, https://doi.org/10.1186/s40035-026-00539-3.